Viemed Healthcare, Inc. (NASDAQ:VMD) Short Interest Up 18.4% in October

Viemed Healthcare, Inc. (NASDAQ:VMD) was the recipient of a significant increase in short interest during the month of October. As of October 31st, there was short interest totalling 361,200 shares, an increase of 18.4% from the October 15th total of 305,100 shares. Based on an average daily trading volume, of 155,500 shares, the days-to-cover ratio is currently 2.3 days. Currently, 1.1% of the company’s stock are short sold.

Viemed Healthcare Trading Down 2.3 %

Shares of VMD opened at $8.85 on Friday. The stock has a market capitalization of $344.62 million, a PE ratio of 32.78 and a beta of 1.43. The company’s fifty day moving average is $8.37 and its 200 day moving average is $7.54. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. Viemed Healthcare has a fifty-two week low of $6.21 and a fifty-two week high of $10.44.

Viemed Healthcare (NASDAQ:VMD) last posted its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of $0.08 by $0.02. The firm had revenue of $58.00 million for the quarter. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%.

Insider Activity

In related news, Director Randy E. Dobbs sold 36,261 shares of Viemed Healthcare stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the sale, the director now owns 107,706 shares of the company’s stock, valued at approximately $999,511.68. This trade represents a 25.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Nitin Kaushal sold 30,000 shares of the company’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $9.56, for a total value of $286,800.00. Following the completion of the transaction, the director now owns 126,843 shares of the company’s stock, valued at $1,212,619.08. The trade was a 19.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 20.00% of the company’s stock.

Institutional Investors Weigh In On Viemed Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. National Bank of Canada FI increased its position in Viemed Healthcare by 91.2% during the third quarter. National Bank of Canada FI now owns 3,346 shares of the company’s stock valued at $25,000 after acquiring an additional 1,596 shares during the last quarter. Evernest Financial Advisors LLC purchased a new position in shares of Viemed Healthcare during the 2nd quarter worth about $66,000. Perkins Coie Trust Co bought a new position in Viemed Healthcare during the 3rd quarter valued at about $73,000. Price T Rowe Associates Inc. MD purchased a new stake in Viemed Healthcare in the 1st quarter worth about $97,000. Finally, PDT Partners LLC bought a new stake in Viemed Healthcare in the third quarter worth about $78,000. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.